EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis

Tarih
2012
Yazar
Tremollieres, Florence
Erel, C. Tamer
Rozenberg, Serge
Schenck-Gustafsson, Karin
Vujovic, Svetlana
Rees, Margaret
Palacios, Santiago
Brincat, Mark
Gambacciani, Marco
Lambrinoudaki, Irene
Moen, Mette H.
Üst veri
Tüm öğe kaydını göster
Özet
Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Bağlantı
http://hdl.handle.net/20.500.12627/159119
https://doi.org/10.1016/j.maturitas.2011.11.010
Koleksiyonlar